Investigating the effect of Icaritin on hepatocellular carcinoma based on network pharmacology

Hepatocellular carcinoma is one of the cancers that kill people in the global population. Icaritin, a small molecule drug approved by NMPA, has demonstrated potential anti-HCC effects. However, its underlying molecular mechanisms remain unclear. We employed a multi-omics approach in this study, incl...

詳細記述

書誌詳細

出版年:	Frontiers in Pharmacology
主要な著者:	Zhong Xue, Fan Zhang, Shaohua Xu, Minyong Chen, Mingzuo Wang, Ming Wang, Fayong Ke, Zhaoshuo Chen, Mingji Zhang
フォーマット:	論文
言語:	英語
出版事項:	Frontiers Media S.A. 2023-05-01
主題:	hepatocellular carcinoma Icaritin multi-omics pharmaco-omics proteomics FYN gene
オンライン･アクセス:	https://www.frontiersin.org/articles/10.3389/fphar.2023.1208495/full